nadp has been researched along with Acute Lymphoid Leukemia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Findley, HW; Finn, NA; Kemp, ML | 1 |
| Abali, EE; Banerjee, D; Bertino, JR; Felczak, K; Gounder, M; Johnson-Farley, N; Kerrigan, JE; Lin, H; Pankiewicz, KW; Roussel, B; Scotto, KW | 1 |
2 other study(ies) available for nadp and Acute Lymphoid Leukemia
| Article | Year |
|---|---|
A switching mechanism in doxorubicin bioactivation can be exploited to control doxorubicin toxicity.
Topics: Antibiotics, Antineoplastic; Cell Line, Tumor; Doxorubicin; Humans; Models, Biological; NADP; Oxidation-Reduction; Oxygen; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Superoxides | 2011 |
A second target of benzamide riboside: dihydrofolate reductase.
Topics: Adenine Nucleotides; Benzamides; Cell Line, Tumor; Down-Regulation; Drug Resistance, Neoplasm; Humans; IMP Dehydrogenase; Methotrexate; Molecular Targeted Therapy; NADP; Nucleosides; Phosphotransferases (Alcohol Group Acceptor); Precursor Cell Lymphoblastic Leukemia-Lymphoma; Tetrahydrofolate Dehydrogenase | 2012 |